Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,464 | 75,176 | 24,388 | 21,897 | 35,619 |
| Receivables | 15,506 | 14,768 | 13,801 | 10,023 | 14,454 |
| Inventories | 1,831 | 2,144 | 2,447 | 3,038 | 3,362 |
| Other current assets | 3,721 | 0 | 0 | 0 | 2,403 |
| TOTAL | $86,234 | $105,988 | $55,001 | $49,632 | $67,588 |
| Non-Current Assets | |||||
| PPE Net | 31,861 | 29,454 | 27,523 | 28,470 | 29,888 |
| Investments And Advances | 256,397 | 256,420 | 19,978 | 24,676 | 262,241 |
| Intangibles | 117,229 | 118,265 | 99,622 | 100,614 | 101,606 |
| Other Non-Current Assets | 44,101 | 91,958 | 330,944 | 333,161 | 96,309 |
| TOTAL | $449,588 | $496,097 | $478,067 | $486,921 | $490,044 |
| Total Assets | $535,822 | $602,085 | $533,068 | $536,553 | $557,632 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 23,208 | 18,529 | 19,151 | 16,585 | 36,261 |
| Accounts payable and accrued liabilities | 25,104 | 23,247 | 27,003 | 29,384 | 44,452 |
| Accrued Expenses | 40,057 | 42,492 | 37,620 | 29,748 | 18,728 |
| Other current liabilities | N/A | N/A | N/A | 7,280 | 8,800 |
| TOTAL | $96,480 | $92,125 | $91,341 | $90,148 | $115,206 |
| Non-Current Liabilities | |||||
| Long Term Debt | 92,258 | 149,459 | 147,027 | 182,958 | 199,088 |
| Deferred Revenues | 4,485 | 4,170 | 4,107 | 3,777 | 3,643 |
| Other Non-Current Liabilities | 87,875 | 97,771 | 100,902 | 93,228 | 93,756 |
| TOTAL | $298,611 | $364,676 | $361,512 | $395,179 | $409,670 |
| Total Liabilities | $395,091 | $456,801 | $452,853 | $485,327 | $524,876 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 280,323 | 262,938 | 242,027 | 209,691 | 181,340 |
| Common Shares | 28 | 28 | 25 | 23 | 18 |
| Retained earnings | -958,279 | -886,776 | -802,753 | -725,013 | -659,818 |
| Other shareholders' equity | -24,364 | -60,176 | -57,759 | -50,496 | -46,566 |
| TOTAL | $140,731 | $145,284 | $80,215 | $51,226 | $32,756 |
| Total Liabilities And Equity | $535,822 | $602,085 | $533,068 | $536,553 | $557,632 |